Breast cancer risk models may incorrectly classify many women
Breast cancer risk estimates for individual women vary substantially depending on which risk assessment model…
Breast cancer risk estimates for individual women vary substantially depending on which risk assessment model…
An independent report into the impact of clinical trials research conducted by Australasia’s largest oncology…
A new study has shown that giving aromatase inhibitors instead of tamoxifen to premenopausal women…
Uterine cancers that developed in patients treated with tamoxifen had fewer PI3K pathway mutations and may…
Leptin, a molecule produced by fat cells, appears to cancel out the effects of the…
A set of compounds developed by scientists at Scripps Research in Florida, USA, target oestrogen-sensitive…
Many women who are genetically susceptible to breast cancer have no idea they can take preventative…
While the drug tamoxifen reduces the risk of developing breast cancer and prevents recurrence, the…
A US research team led by University of Southern California scientists has found that a…
Among women with hormone receptor (HR)-positive, HER2-negative breast cancer with a high clinical risk (determined…